Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lingfeng Tang

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
World Journal of Surgical Oncology|January 30, 2022
Exploring the influencing factors of the pathologic complete response in estrogen receptor-positive, HER2-negative breast cancer after neoadjuvant chemotherapy: a retrospective studyLingfeng Tang, Xiujie Shu, Gang Tu
Scientific Reports|June 26, 2026
Interpretable machine learning reveals the synergistic impact of essential hypertension on early recurrence in triple-negative breast cancerZhenhong Du, Gang Tu, Lingfeng Tang
Oncology Letters|March 21, 2020
Identification of candidate RNA signatures in triple-negative breast cancer by the construction of a competing endogenous RNA network with integrative analyses of Gene Expression Omnibus and The Cancer Genome Atlas dataPing Yan, Lingfeng Tang, Li Liu, et al.
Translational Cancer Research|February 12, 2026
Development and validation of a herb-related gene signature for prognosis prediction and therapeutic response assessment in breast cancerJihan Qiu, Hanzhi Li, Lingfeng Tang, et al.
Methods (San Diego, Calif.)|April 2, 2014
Tools and methods for studying the Drosophila JAK/STAT pathwayQian Chen, Michelle Giedt, Lingfeng Tang, et al.
Translational Oncology|April 4, 2026
Pan-cancer analysis identifies FKBP10 as a regulator of tumor immunosuppression and therapeutic responseYan Li, Jian Chen, Siyan Li, et al.
Discover Oncology|July 27, 2025
FKBP10 expression and TP53 mutation predict prognosis and chemotherapy response in triple-negative breast cancerYan Li, Chi Zhang, Jian Chen, et al.
ACS Nano|March 4, 2024
S-NiSe/HG Nanocomposites with Balanced Dielectric Loss Encapsulated in Room-Temperature Self-Healing Polyurethane for Microwave Absorption and Corrosion ProtectionYunfei Zhang, Lei Zhang, Lingfeng Tang, et al.
Scientific Reports|May 23, 2024
Prognosis and influencing factors of ER-positive, HER2-low breast cancer patients with residual disease after neoadjuvant chemotherapy: a retrospective studyLingfeng Tang, Linshan Jiang, Xiujie Shu, et al.
Frontiers in Oncology|January 6, 2023
Efficacy evaluation of neoadjuvant chemotherapy in patients with HER2-low expression breast cancer: A real-world retrospective studyLingfeng Tang, Zhenghang Li, Linshan Jiang, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
World Journal of Surgical Oncology|January 30, 2022
Exploring the influencing factors of the pathologic complete response in estrogen receptor-positive, HER2-negative breast cancer after neoadjuvant chemotherapy: a retrospective studyLingfeng Tang, Xiujie Shu, Gang Tu
Scientific Reports|June 26, 2026
Interpretable machine learning reveals the synergistic impact of essential hypertension on early recurrence in triple-negative breast cancerZhenhong Du, Gang Tu, Lingfeng Tang
Oncology Letters|March 21, 2020
Identification of candidate RNA signatures in triple-negative breast cancer by the construction of a competing endogenous RNA network with integrative analyses of Gene Expression Omnibus and The Cancer Genome Atlas dataPing Yan, Lingfeng Tang, Li Liu, et al.
Translational Cancer Research|February 12, 2026
Development and validation of a herb-related gene signature for prognosis prediction and therapeutic response assessment in breast cancerJihan Qiu, Hanzhi Li, Lingfeng Tang, et al.
Methods (San Diego, Calif.)|April 2, 2014
Tools and methods for studying the Drosophila JAK/STAT pathwayQian Chen, Michelle Giedt, Lingfeng Tang, et al.
Translational Oncology|April 4, 2026
Pan-cancer analysis identifies FKBP10 as a regulator of tumor immunosuppression and therapeutic responseYan Li, Jian Chen, Siyan Li, et al.
Discover Oncology|July 27, 2025
FKBP10 expression and TP53 mutation predict prognosis and chemotherapy response in triple-negative breast cancerYan Li, Chi Zhang, Jian Chen, et al.
ACS Nano|March 4, 2024
S-NiSe/HG Nanocomposites with Balanced Dielectric Loss Encapsulated in Room-Temperature Self-Healing Polyurethane for Microwave Absorption and Corrosion ProtectionYunfei Zhang, Lei Zhang, Lingfeng Tang, et al.
Scientific Reports|May 23, 2024
Prognosis and influencing factors of ER-positive, HER2-low breast cancer patients with residual disease after neoadjuvant chemotherapy: a retrospective studyLingfeng Tang, Linshan Jiang, Xiujie Shu, et al.
Frontiers in Oncology|January 6, 2023
Efficacy evaluation of neoadjuvant chemotherapy in patients with HER2-low expression breast cancer: A real-world retrospective studyLingfeng Tang, Zhenghang Li, Linshan Jiang, et al.
Pageof 4